W e have begun a systematic analysis of expression differences between vascular smooth muscle tissues. We chose to begin with an analysis of the media of aorta and vena cava because of the possibility of isolating relatively homogenous cellular populations and because of the distinct functional requirements, embryological origins, and hemodynamic environments of these 2 tissues.
The present study, using a cDNA array containing 35% of human named genes (4048 of the Ϸ10 900 functionally identified human genes in UniGene Build No. 109 of the National Center for Biotechnology Information human Unigene collection), identified 68 genes that are consistently expressed at higher levels in the aorta. No genes were more consistently highly expressed by the vena cava. One of these aortic markers, regulator of G-protein signaling (RGS) 5, showed extreme levels of differential expression. Together, these genes offer a molecular definition of the phenotypes of these 2 types of smooth muscle.
Materials and Methods

Array Hybridization
Research Genetics GF211 cDNA arrays (4048 human genes) were used as specified. Equivalent amounts of RNA per vessel pair were used to synthesize cDNA probes, and equivalent counts per minute were added to hybridizations. Washed blots were exposed to phosphor image screens and scanned on a Storm phosphor imager (Molecular Dynamics). Expression was quantified from scans with similar intensity and background, using Pathways software (Research Genetics). Ratios were calculated for each animal and then averaged.
Northern, Dot Blot, and In Situ Hybridization
Total RNA (15 g) from macaque or rat was run, transferred, and hybridized as described 1 with multiprime probes (Amersham) synthesized from sequence-verified clones of human and mouse RGS5 (IMAGE clones 853809 and 1853118, respectively [American Type Culture Collection]) and of human nonmuscle myosin heavy chain B (NMMHC-B) (IMAGE clone 823886), and then probed with a 28S rRNA primer as described. 2 Washes were as follows: 3 cycles of 5 minutes each at room temperature in 5ϫ SSC, 0.1% SDS, and 2 cycles of 20 minutes each at 57°C (rat) or 55°C (macaque) in 0.3ϫ SSC, 0.1% SDS. Human Northern blot No. 7791-1 (Clontech Laboratories, Inc) containing 2 g poly(A) RNA from adult and fetal heart, aorta, and 5 regions of the heart was probed with human RGS5, then G3PDH as specified. Human RNA master dot blot No. 7770-1 (Clontech) containing 33 tissue, 14 brain region, and 7 fetal poly(A) RNAs (89 to 514 ng each) was probed as specified with human clones for RGS5 and then human ubiquitin.
In situ hybridization was performed on cross sections of aorta and vena cava taken directly adjacent to vessel segments snap-frozen for array analyses. These tissues were immersion-fixed for 48 hours in 10% formalin and embedded in paraffin. Sections were cut onto coated slides and in situ hybridization was performed using 35 Slabeled riboprobes (sense and antisense) transcribed from human RGS5 cDNA No. 853809 as described. 3 
Tissue Samples and RNA Isolation
Three human aortas, 2 from males (age 32 and 33 years) and 1 from a female (age 47 years), were isolated from donor hearts obtained from the University of British Columbia-St. Paul's Hospital. Samples were stripped of adventitia and endothelium and snap-frozen in liquid nitrogen.
Macaque tissues were obtained from 5 surgically menopausal (ovariectomized) female cynomolgus macaque monkeys (Macaca fascicularis). 4 These monkeys made up the control group from a study of the effects of isoflavones on bypass graft intimal hyperplasia and iliac artery angioplasty. Animals were not administered isoflavones but underwent bypass graft placement between the distal aorta and right iliac artery and angioplasty of the left common iliac artery. The bypass graft originated at the most distal abdominal aorta, with the proximal anastomosis adjacent to the aortic bifurcation and distal anastomosis to the external iliac artery. The vena cava and aorta used for arrays were removed well proximal to the site of surgery (distal thoracic aorta; vena cava from the diaphragm to just above the aortic anastomosis) 6 weeks after surgery. After sedation with ketamine (15 mg/kg IM) and butorphanol (0.05 mg/kg IM), animals were anticoagulated with heparin (300 U/kg IV) and deeply anesthetized with sodium pentobarbital (100 mg/kg IV). The adventitia was stripped from both the aorta and the vena cava, and the endothelium was removed from the aorta but not the vena cava. Tissues were snap-frozen in liquid nitrogen. Twenty male Sprague-Dawley rats (Rattus norvegicus) (ZivigMiller) were housed and fed according to protocols approved by the Animal Care Committee of the University of Washington. Rats were anesthetized and euthanized, and tissues were processed as previously described. 2 All RNA was isolated as previously described. 5 
Results
General Comparison of Human and Macaque Array Hybridization
Samples of RNA from 5 pairs of macaque aortas and vena cavas were used to probe a cDNA array containing 4048 human genes. Genes were defined as expressed if hybridization was Ն1.5 times the average background (before normalization in Pathways software to overall hybridization strength). The informativeness of macaque probes on human filters in terms of the total number of positive responding spots was a concern, because all arrayed targets consist of Ϸ1000 bp of the 3Ј end of each gene and contain complete 3Ј untranslated regions, areas of low interspecies homology. To quantify general hybridization patterns, we hybridized cDNA probes from human aorta (nϭ3) and from macaque aorta and vena cava (both nϭ5), then compared the average number of genes expressed by the above definition. The number of genes detected in human was Ϸ200 to 500 greater than in macaque (human aorta, 3855Ϯ115 [meanϮSEM]; macaque aorta, 3367Ϯ115; and macaque vena cava, 3635Ϯ181), indicating possible species specific differences in 3Ј noncoding domains or, possibly, species differences in expression.
Identification of Differentially Expressed Genes
To have objective criteria for identifying consistently differentially expressed genes, we established categories of ratio and array hybridization level for this study (Table 1) . After analyzing the data for the 5 independent macaque comparisons, there were 68 genes that fit these criteria. All were higher in the aorta (Table 2 ). Of these, only RGS5 was expressed Ͼ10-fold, at 46.5Ϯ12.6 SEM. RGS5 had the highest level of differential expression in each macaque. Levels were undetectable, or barely detectable, in vena cava, suggesting an "all-or-nothing" expression. The array hybridization images for class IA genes are shown in Figure 1A . Expression ratios of the 68 differentially expressed genes are graphed in Figure 1B .
Northern Analysis and In Situ Hybridization
We verified the array-based quantification by further examining the expression of the 2 most highly expressed genes, RGS5 and NMMHC-B. First, we examined macaque aorta and vena cava by Northern analyses (Figure 2A ). RGS5 was most highly expressed in macaque aorta, followed by carotid artery, heart, and vena cava, with little expression detected in skeletal muscle or liver. NMMHC-B was most highly expressed in aorta, followed by vena cava and then the carotid artery. After normalization to 28S rRNA hybridization (Table  3) , the Northern blot aorta-to-vena cava ratio was quantified as 45-fold for RGS5 and 5-fold for NMMHC-B, very close to the mean array values. Macaque message sizes were consistent with the published human sizes, 6 with 2 major RGS5 bands at Ϸ7.0 and Ϸ2.1 kb and 1 NMMHC-B band at Ϸ7.5 kb. 7 We further examined RGS5 because of its large differential expression ratio. To compare human aorta RGS5 message levels to heart, the highest-expressing human tissue examined in the literature, 6 we probed a Clontech Northern blot containing RNA samples of aorta, fetal and adult heart, and 5 distinct heart regions ( Figure 2B ). RGS5 message levels in the aorta were at least 12-fold higher than any region of the heart (Table 4 , top). RGS5 message is reported to be highly expressed in mouse heart and very low in liver, 8 but has never been examined in rodent vessels. We compared RGS5 expression in rat aorta, carotid artery, and vena cava with that in heart and liver by Northern analysis ( Figure 2C) . The RGS5 message level was equally high in rat aorta and heart (Table 4, middle) and 2.3 times higher than the vena cava, whereas the carotid artery had lower expression than the vena cava, differing from macaque and human expression. The rat message consisted of a single band the same size as mouse heart (data not shown). The rat and macaque data establish RGS5 as a marker differentiating aorta from carotid artery and aorta from vena cava, but show that there are distinct species differences in expression levels in vessels. Finally, we examined the expression of RGS5 on a human dot blot (Clontech) containing RNAs from 47 adult and 7 fetal tissues (Figure 3 ). Twentynine tissues had higher expression than skeletal muscle, a moderate-expression tissue 6 ; the top 15 are quantified in Table 4 , bottom. The 6 highest-expressing tissues in order (beginning with the highest) were aorta, small intestine, stomach, heart (4.6-fold lower than the aorta), adrenal gland, and fetal heart.
Adams et al Expression Profiles of Aorta and Vena Cava 625
To localize the RGS5 transcript in vivo, we performed in situ hybridization on macaque aorta and vena cava (Figure 4) . Hybridization in the aorta from the antisense probe was seen uniformly throughout the media, well above the sense probe background level, whereas the vena cava antisense probe hybridization was very similar to the background sense hybridization. No hybridization was seen in the endothelium. The presence of endothelium was confirmed by examination of hematoxylin and eosin-stained sections (Figures 4a and  4b ) and by immunohistochemistry using Von Willebrand factor antibody staining (data not shown). One possible explanation of differential expression of RGS5 could have been the presence of RNA from vasa vasorum, as they are present in arteries but not veins. 9 This remains a formal possibility for other aorta differentially expressed genes.
Discussion
Our analysis of aorta versus vena cava reveals 68 genes that mark the aorta by overexpression, including 2 transcripts Ratios are the average of individual macaque aorta (Ao) to vena cava (VC) comparisons (nϭ5). Mean intensity (Int) values are included as a guide for expression levels; individual macaque intensities were used to calculate mean ratios (R). All 68 consistently differentially expressed genes had SEMs less than two-thirds of their average ratios.
*Array housekeeping genes.
previously identified with the aorta, aortic preferentially expressed gene 1 (APEG-1) 10 and elastin. 11, 12 It is important to stress that we have examined 5 individual animals to produce this data set, eliminating false-positive results due to animal variation in elevations of gene expression or random measurement error. Genes were only declared differentially expressed if mean expression ratios were Ͼ1.5-fold. All 5 individual animal ratios were Ͼ1.3-fold; SEMs were less than two-thirds (given that a gene had to be differential in all animals by 1.3-fold, this fact in effect ensured that the SEM was a measurement of variation in differential ratio). All differential genes hybridized consistently above 1.5-fold the average background. Although an expression ratio of 1.3 is small, in an analysis of message expression using cDNA arrays, Geiss et al 13 demonstrated that even ratios as low as 1.3 to 1.4 on the array can be statistically meaningful for genes with low SE. They showed that Northern blots produce higher ratios than do arrays. Thus, we expect that most of the 68 genes are truly differentially expressed. We have shown previously that this Research Genetics cDNA array produces values that agree with independent methods of expression measurement. 14 Moreover, 44 of the 68 genes were expressed at ratios of 2-fold or greater.
The most striking aspect of the data set is the expression of one gene, RGS5. RGS5 is remarkably higher in average ratio than any other transcript compared between aorta and vena cava. Nevertheless, we suggest that it is the data set as a whole that begins the molecular description of the arterial and venous phenotypes. Golub et al 15 have recently compared acute lymphoblastic leukemia with acute myeloid leukemia. Using more sophisticated analysis than currently available to us, these authors found a set of only 50 genes out of 6817 that Blots were stripped and reprobed with 28S rRNA hybridizations in panels A and C and with G3PDH in panel B for loading quantification. A, Macaque tissues. H indicates heart; Skm, skeletal muscle; Ao, aorta; CA, carotid artery; VC, vena cava; and Lv, liver. B, Human aorta and heart tissue (Clontech). FH indicates fetal heart; H, heart; Ao, aorta; AP, apex of heart; LA, left atrium; RA, right atrium; LV, left ventricle; and RV, right ventricle. C, Rat tissues. Abbreviations as in panels A and B. Panels A and C, Locations of 28S and 18S rRNAs are shown on the left at 4.9 and 1.7 kb, respectively. RGS5 (top) and NMMHC-B (bottom) hybridizations were normalized, first to 28S rRNA hybridization to adjust to loading differences, then to normalized skeletal muscle (Skm) hybridization. All hybridizations were quantified from phosphor imager scans.
could be used as a pattern to distinguish between these 2 generally related neoplasms. Similarly, the 68 genes reported here represent a consistently differentially expressed set that together constitute a phenotype for aortic and vena cava smooth muscle.
A few of the genes in this set of 68 have been examined previously in vascular smooth muscle contexts. Four genes showing aortic expression, APEG-1, elastin, NMMHC-B, and vimentin have previously been identified as markers of the intima. APEG-1 has been shown in rats to be differentially expressed between aorta and vena cava and downregulated after carotid balloon injury. 16 NMMHC-B, also called SMemb, has been previously reported to be differentially expressed in vivo in vascular smooth muscle, in human normal intima and intima of coronary arteries after angioplasty, 17 and in 2 rabbit models of intima formation. 18 Vimentin has been shown to be expressed in balloon-injured rat carotid neointima, whereas another intermediate filament, desmin, disappears 19 and is expressed in "synthetic" smooth muscle cells in culture. 20 Elastin has also been shown to be a marker between rat smooth muscle cell types of different embryological origin and is upregulated after carotid artery balloon injury in vivo. 21 Secreted protein acidic and rich in cysteine, seen here as an arterial marker, has also been shown to be differential between smooth muscle subtypes in vitro but is not modulated in expression after carotid artery balloon injury. 22 *Quantified Northern analysis of RGS5 in human aorta and heart. RGS5 hybridizations were normalized first to GAPDH hybridizations for loading adjustment and then to the fetal heart hybridization level.
†Quantified expression of RGS5 in rat tissues. RGS5 levels were normalized first to 28S rRNA levels to adjust to loading differences and then to normalized skeletal muscle RGS5 hybridization. Hybridizations were quantified from phosphor imager scans.
‡The 15 tissues with highest RGS5 message levels. RGS5 hybridizations were normalized first to ubiquitin hybridization to adjust to loading differences and then to normalized skeletal muscle RGS5 hybridization. Hybridizations were quantified from phosphor imager scans. . A1 through A8, respectively, Whole brain, amygdala, caudate nucleus, cerebellum, cerebral cortex, frontal lobe, hippocampus, and medulla oblongata. B1 through B8, Occipital lobe, putamen, substantia nigra, temporal lobe, thalamus, subthalamic nucleus, spinal chord, and blank. C1 through C8, Heart, aorta, skeletal muscle, colon, bladder, uterus, prostate, and stomach. D1 through D8, Testis, ovary, pancreas, pituitary gland, adrenal gland, thyroid gland, salivary gland, and mammary gland. E1 through E8, Kidney, liver, small intestine, spleen, thymus, peripheral leukocyte, lymph node, and bone marrow. F1 through F4, Appendix, lung, trachea, and placenta. F5 through F8, Blank. G1 through G8 (fetal tissue), brain, heart, kidney, liver, spleen, thymus, lung, and blank. H1 through H8 (controls), 100 ng yeast total RNA, 100 ng yeast tRNA, 100 ng Escherichia coli rRNA, 100 ng E. coli DNA, 100 ng poly r(A), 100 ng human C o t-1 DNA, 100 ng human DNA, and 500 ng human DNA.
As for the remainder of the data set, it is intriguing to see that only a minority of these genes has been of traditional interest to vascular biologists, suggesting that there are many novel aspects of arteries and veins yet to functionally characterize. Among the aortic genes not previously studied in vascular biology, the high level of differential expression of RGS5 singles it out for our attention. RGS5 is currently an "orphan" G-protein pathway regulator, and its exact functions need to be characterized. The core function of RGS proteins is to regulate G-protein signal strength and duration by binding to and dephosphorylating G␣ subunits. 8, [22] [23] [24] [25] [26] Additionally, there is evidence for both inhibitor and effector (signal integration) G-protein signaling from 2 multidomain RGS proteins, p115RhoGEF 27, 28 and PDZRhoGEF, 29 suggesting that the role RGS5 plays in arteries may be quite complex. RGS4, RGS5, RGS8, and RGS16 are among the shortest RGS proteins and share homology outside their RGS domains, suggesting they constitute a subfamily, with RGS4 and RGS5 being the most similar. 30 -33 In transgenic mouse overexpression studies, high levels of RGS4 inhibit cardiac ventricular hypertrophy in response to cardiac pressure overload after thoracic aortic constriction. 34 These remodeling processes are required for adaptation and survival of transgenics. Also, in transgenic mouse overexpression studies of G␣q (a binding partner of RGS4), high expression levels cause cardiac hypertrophy. 35, 36 These data for RGS4 overexpression in heart, and our expression data for RGS5 in vessels, suggest that RGS5 could be a counterpart in arteries to the RGS4-regulated system of balance between activation and deactivation of G proteininduced hypertrophic signaling in the heart. Arteries, like hearts, adapt to increased tension by remodeling, producing a thick vessel wall able to generate a stronger contractile response. 37 Considering the known role for RGS4 in heart accommodation to increased pressure and its structural similarities to RGS5, we speculate that RGS5 might also be involved in the adaptation of arteries to normal and pathological pressure changes. However, until a transgenic overexpression of RGS5 is performed and tested after aortic constriction, there will be no direct evidence to determine whether RGS5 is regulating pressure-induced hypertrophy in arteries.
In summary, our analysis of 4048 genes, combined with the Ϸ20 000 genes expected to be expressed in an average tissue, 38 suggests there will be roughly 340 genes marking the aortic versus the venous phenotype, including perhaps 4 genes of the ratio magnitude of RGS5. It is intriguing that we found no genes overexpressed in vein versus artery. One possible explanation is that the arterial phenotype is built on a basic veinlike phenotype. We speculate that the most highly overexpressed aortic gene, RGS5, could play a role in control of transcription of the entire aortic phenotype and, based on homology to other RGS proteins, may play an aortic-specific role in regulation of responses to G-protein-mediated vasoactive signals. 35 S-labeled riboprobes to human RGS5. Hematoxylin counterstain provides orientation of the aortic wall (a, lumen at right, adventitia at left) and vena cava (b, lumen and thin media at center with surrounding adventitia). c and d, Same sections viewed with darkfield microscopy show intense hybridization of the antisense probe to RGS5 message in the aorta (c) but minimal hybridization in vena cava (d). Adjacent sections (e and f) were hybridized with sense probe to control for nonspecific background. Magnification, ϫ200, all panels.
